Gazit-Globe Announces That it Has Chosen to Terminate the Sale Process for Its Israeli Portfolio
Mar 02, 2016 07:00 am UTC| Business
TEL-AVIV, Israel, March 02, 2016 -- Gazit-Globe (NYSE:GZT) (TSX:GZT) (TASE:GZT), one of the world's leading multi-national real estate companies focused on the management, acquisition, development and redevelopment of...
Mar 02, 2016 07:00 am UTC| Business
AUSTIN, Texas, March 02, 2016 -- XBiotech (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, announced today that its Medical Director Michael Stecher, M.D., will be included in a delegation assembled by...
UTStarcom to Announce Fourth Quarter and Full Year 2015 Financial Results on Friday, March 11, 2016
Mar 02, 2016 06:26 am UTC| Business
HONG KONG, March 02, 2016 -- UTStarcom (NASDAQ:UTSI), a global telecommunications infrastructure provider, will announce its financial results for fourth quarter and full year ended December 31, 2015, before the U.S....
Mar 02, 2016 06:07 am UTC| Business
IRVINE, Calif. and HERSTAL, Belgium, March 2, 2016 -- MDxHealth SA (Euronext: MDXH.BR), today announced that its ConfirmMDx for Prostate Cancer test has been included in the United States' 2016 National Comprehensive...
Targovax ASA: Interim report fourth quarter 2015
Mar 02, 2016 06:05 am UTC| Business
Integration process continues, utilizing cross organization expertise and exploring advantages in combining product platforms Extending studies through external collaborations. Entered agreements with US Ludwig...
MorphoSys AG Reports Results for Fiscal Year 2015
Mar 02, 2016 06:04 am UTC| Business
MARTINSRIED / MUNICH, Germany, March 2, 2016 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced financial results for the year ending December 31, 2015, as well as a financial and...
Mar 02, 2016 06:00 am UTC| Business
MONT-SAINT-GUIBERT, Belgium, March 02, 2016 -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular...